More on LTRN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lantern Pharma (NQ:LTRN)
Delayed: 0.64 --0 (-0%)
Prev. Close $0.64  
Open$0.65 
52 Wk High$ 
52 Wk Low$ 
Day High$0.66 
Day Low$0.59 
P/E N/A  
EPS$ 
Volume196,568 

Friends, Peers and Foes (?): DVLT, CAST, BSIN, RDZN, COCH (more...)

Oct 21, 2026 06:02 AM Form ARS Lantern Pharma Inc. For: Dec 31
Oct 19, 2026 04:15 PM Form DEF 14A Lantern Pharma Inc. For: Oct 19
Oct 17, 2026 12:37 PM Powering the AI Economy: New to The Street Show #776 Premieres Tonight on Bloomberg Television
Oct 13, 2026 12:52 PM Form SCHEDULE 13G/A Lantern Pharma Inc. Filed by: Empery Asset Management, LP
Oct 10, 2026 10:57 AM New to The Street Show 775 Premieres Tonight on Bloomberg Television Across the United States, Latin America, MENA and Southeast Asia, Featuring American Fusion, HPB, T-REX Acquisition Corp. and SyncM
Oct 8, 2026 04:05 PM Form PRE 14A Lantern Pharma Inc. For: Oct 08
Oct 8, 2026 08:00 AM Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
Oct 7, 2026 08:31 AM Lantern Pharma gets Taiwan approval for next phase of LP-300 trial
Oct 7, 2026 08:31 AM Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC
Oct 1, 2026 04:01 PM Form 8-K Lantern Pharma Inc. For: Sep 25
View All Articles

Entities mentioned with LTRN

View All Entities